Zepbound 5 mg: the first maintenance dose
The short answer
Zepbound 5 mg is the second step on the label: you move to it after 4 weeks on 2.5 mg. It's the lowest recommended maintenance dose for weight reduction, but not for sleep apnea. LillyDirect self-pay vials cost $399 per 28-day fill, and a full year at 5 mg costs $5,187.
Key takeaways
- Zepbound 5 mg comes after 4 weeks on 2.5 mg. That step is fixed for every approved use.
- For weight reduction, 5 mg is a maintenance dose you can stay on. For obstructive sleep apnea, it's only a step.
- Moving to 7.5 mg is optional, after at least 4 weeks here. Your prescriber decides.
- LillyDirect self-pay is $399 per 28-day fill, and a late refill costs the same.
- A full year at 5 mg through LillyDirect is $5,187.
What the label says about Zepbound 5 mg
Once weeklyA labelled maintenance doseAt least 28 days before any increase
Maintenance dose for weight reduction; not a maintenance dose for OSA (10 mg or 15 mg).
After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly. The dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose [see Dosage and Administration (2.2)].
Comes as: KwikPen (multi-dose, 4 weekly doses); Multi-dose vial (4 weekly doses); Single-dose pen; Single-dose vial.
FDA label: Revised: 8/2026 (DailyMed version 40)
Zepbound dose schedule from the label
ZepboundRevised: 8/2026 (DailyMed version 40)
Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.
Supply per fill
| Form | Doses per device | Doses per fill | Days per fill | Fills per year |
|---|---|---|---|---|
| KwikPen (multi-dose, 4 weekly doses) | 4 | 4 | 28 | 13 |
| Multi-dose vial (4 weekly doses) | 4 | 4 | 28 | 13 |
| Single-dose pen | 1 | 4 | 28 | 13 |
| Single-dose vial | 1 | 4 | 28 | 13 |
Track run-out and refill dates with the supply tracker.
Zepbound 5 mg: every way to pay, cheapest first
This table uses the 5 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.
| How you pay | Form | Per fill | Cost per mg | Conditions | Source |
|---|---|---|---|---|---|
| Manufacturer savings card (commercial insurance, drug covered) | Single-dose pen | $25 | $1.25 | ConditionsCommercial drug insurance that covers the Zepbound single-dose pen. Pay as little as $25 for a 1-, 2- or 3-month fill; maximum savings $100 per 1-month, $200 per 2-month or $300 per 3-month fill, and $1,300 per calendar year; up to 13 fills per year. Month is 28 days and up to 4 pens. Government beneficiaries (Medicare, Medicaid, TRICARE, VA etc.) excluded. Card expires 12/31/2026. | zepbound.lilly.com |
| Medicare GLP-1 Bridge | KwikPen (multi-dose, 4 weekly doses) | $50 | $2.50 | ConditionsMedicare GLP-1 Bridge demonstration, July 1, 2026 through December 31, 2027. For adults 18 or older with Medicare Part D drug coverage (standalone PDP, MA-PD, SNP, EGWP or LI NET) who meet the BMI criteria when starting GLP-1 therapy (BMI 35+, or BMI 30+ with diastolic heart failure, uncontrolled hypertension or CKD stage 3a+, or BMI 27+ with prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease). Not for people already getting GLP-1s through their Part D plan, or using the drug for type 2 diabetes, sleep apnea or fatty liver disease. Prior authorization required (valid through December 31, 2027 unless you change drugs). $50 copay per one-month supply (28 or 30 days); it does not count toward the Part D deductible or out-of-pocket limit and cannot be reduced by Extra Help. Zepbound is covered as the KwikPen only, prescribed for weight management; single-dose vials and pens are not covered. Pen needles are sold separately. | medicare.gov |
| LillyDirect self-pay | KwikPen (multi-dose, 4 weekly doses) | $399 | $19.95 | ConditionsSelf-pay only through LillyDirect (no insurance used). Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. Program is not insurance; Lilly may change or end it at any time. | lilly.com |
| LillyDirect self-pay | Single-dose vial | $399 | $19.95 | ConditionsSelf-pay only through LillyDirect (no insurance used). Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. Program is not insurance; Lilly may change or end it at any time. | lilly.com |
| Manufacturer savings card (commercial insurance, drug not covered) | KwikPen (multi-dose, 4 weekly doses) | $399 | $19.95 | ConditionsCommercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $399 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $115. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately. | zepbound.lilly.com |
| Manufacturer savings card (self-pay, no insurance) | KwikPen (multi-dose, 4 weekly doses) | $399 | $19.95 | ConditionsZepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $399 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $115. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately. | zepbound.lilly.com |
| TrumpRx | Single-dose vial | $399 | $19.95 | ConditionsOut-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms. | trumprx.gov |
| Manufacturer savings card (commercial insurance, drug not covered) | Single-dose pen | $499 | $24.95 | ConditionsCommercial drug insurance that does not cover the Zepbound single-dose pen. Pay as low as $499 per 1-month fill (28 days, up to 4 pens); maximum monthly savings is the wholesale acquisition cost minus $499; up to 13 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026. | zepbound.lilly.com |
| Ro | KwikPen (multi-dose, 4 weekly doses) | $548 | $27.40 | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. | ro.co |
Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.
If you miss a dose of Zepbound
You can move your weekly day, as long as there are at least 3 days between doses.
The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).
If it has been more than 4 days, skip it and take your next dose on your usual day.
If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
If it has been 4 days or less, take it now and carry on with your usual weekly day.
If a dose is missed, instruct patients to administer ZEPBOUND as soon as possible within 4 days (96 hours) after the missed dose.
Enter your own dates in the missed-dose helper. If you are unsure, call your prescriber or pharmacist; never take two doses to catch up.
Zepbound 5 mg is the one step nobody skips. After four weeks at the 2.5 mg starting dose, the label says to go up to 5 mg once weekly. What happens next is where paths divide, because 5 mg is also the first dose the label lets you stay on.
A required step and a maintenance dose
The label is direct: “After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly.” It then lists the recommended maintenance doses (doses you stay on) for weight reduction and long-term maintenance as 5 mg, 10 mg or 15 mg.
For obstructive sleep apnea the list is shorter: 10 mg or 15 mg. So if you take Zepbound for sleep apnea, 5 mg is a step and not a place to stop.
Further increases are allowed “in 2.5 mg increments, after at least 4 weeks on the current dose,” which makes 7.5 mg the next step up. The titration schedule tool shows the earliest date for each step. Titration means raising a dose in steps.
What the label reports at 5 mg
The label tested 5 mg in Study 1, in adults without diabetes. Weight was measured after 72 weeks of treatment:
- Average body-weight change was -15.0% on 5 mg, against -3.1% on placebo (an inactive treatment).
- 85.1% of people on 5 mg lost at least 5% of their body weight, against 34.5% on placebo.
In the label’s pooled safety table, which combines results from its trials, nausea was reported by 25% of people on 5 mg and 8% on placebo. Diarrhea was reported by 19% and constipation by 17%. These are trial averages, not a prediction for one person.
Price at this step
Moving from 2.5 mg to 5 mg raises the LillyDirect self-pay price from $299 to $399 per 28-day fill. Two things are specific to 5 mg:
- No refill deadline. The 45-day refill rule starts at 7.5 mg. At 5 mg, a late refill costs the same as an on-time one.
- It’s the cheapest dose you can hold. A full year at 5 mg is $5,187. A year at 10 mg with on-time refills is $5,837.
The Zepbound cost page covers the savings card and insurance routes, and the cost calculator prices your own path.
Supply and forms
A fill is four single-dose vials for 28 days, so the minimum 4 weeks at 5 mg is one fill. If you settle here, you’ll buy 13 fills a year.
The 5 mg strength comes as a single-dose vial, a single-dose pen, a KwikPen and a multi-dose vial. The vial and KwikPen share the self-pay price above. The Zepbound guide explains each form, and the dosing hub sets this ladder beside other medicines.
Where to get Zepbound
1. Manufacturer savings card (commercial insurance, drug covered)
$25 per fill at 5 mg
2. Medicare GLP-1 Bridge
$50 per fill at 5 mg
3. LillyDirect self-pay
$399 per fill at 5 mg
Source: lilly.comGo to the program page
4. LillyDirect self-pay
$399 per fill at 5 mg
Source: lilly.comGo to the program page
5. Manufacturer savings card (commercial insurance, drug not covered)
$399 per fill at 5 mg
Telehealth programs that prescribe Zepbound
- Ro · $548 per fill including $149 membershipVisit Ro
Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.
Frequently asked questions
Can you stay on Zepbound 5 mg?
For weight reduction, yes. The label names 5 mg, 10 mg and 15 mg as the recommended maintenance doses (doses you stay on). For obstructive sleep apnea, the recommended maintenance dose is 10 mg or 15 mg, so 5 mg is a step on the way up for that use. Whether you stay at 5 mg or go higher is your prescriber's decision.
How much weight did people lose on Zepbound 5 mg?
In Study 1 on the label, adults without diabetes who took 5 mg had an average body-weight change of -15.0% at 72 weeks, compared with -3.1% on placebo (an inactive treatment). In that study, 85.1% of people on 5 mg lost at least 5% of their body weight, against 34.5% on placebo. Everyone also followed a reduced-calorie diet and increased activity.
How much does Zepbound 5 mg cost per month?
LillyDirect self-pay is $399 for a 28-day fill of four single-dose vials, and the 5 mg KwikPen is the same price. TrumpRx lists $399 and sends the order to LillyDirect. A year holds 13 fills of 28 days, so twelve months at 5 mg comes to $5,187.
When can you go from Zepbound 5 mg to 7.5 mg?
The label says the dose may be increased in 2.5 mg increments after at least 4 weeks on the current dose. So the earliest move from 5 mg to 7.5 mg is after 4 weeks, which is one fill. The label makes this step optional, and your prescriber decides whether and when it happens.
Sources (7)
- 1.FDA label (DailyMed): Zepbound prescribing information, section 2.2
“The recommended maintenance dosage is 5 mg, 10 mg, or 15 mg, injected subcutaneously once weekly.”
- 2.FDA label (DailyMed): Zepbound prescribing information, section 14.1
“In both trials, weight reduction was assessed after 72 weeks of treatment (at least 52 weeks at maintenance dose).”
- 3.FDA label (DailyMed): Zepbound prescribing information, section 14.1, Table 2
“Table 2: Changes in Body Weight at Week 72 in Studies 1 and 2 in Patients with Obesity or Overweight. % Change from baseline: Study 1 Placebo N = 643: -3.1; Study 1 ZEPBOUND 5 mg N = 630: -15.0; Study 1 ZEPBOUND 10 mg N = 636: -19.5; Study 1 ZEPBOUND 15 mg N = 630: -20.9; Study 2 Placebo N = 315: -3.2; Study 2 ZEPBOUND 10 mg N = 312: -12.8; Study 2 ZEPBOUND 15 mg N = 311: -14.7”
- 4.FDA label (DailyMed): Zepbound prescribing information, section 14.1, Table 2
“Table 2: Changes in Body Weight at Week 72 in Studies 1 and 2 in Patients with Obesity or Overweight. % of Patients losing ≥5% body weight: Study 1 Placebo N = 643: 34.5; Study 1 ZEPBOUND 5 mg N = 630: 85.1; Study 1 ZEPBOUND 10 mg N = 636: 88.9; Study 1 ZEPBOUND 15 mg N = 630: 90.9; Study 2 Placebo N = 315: 32.5; Study 2 ZEPBOUND 10 mg N = 312: 79.2; Study 2 ZEPBOUND 15 mg N = 311: 82.8”
- 5.
- 6.
- 7.
